Interleukin-6 receptor antagonists in pregnancy: a reason for cautious optimism
- 5 August 2024
- journal article
- editorial
- Published by Elsevier in The Lancet Rheumatology
- Vol. 6 (9) , e592-e593
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Use of interleukin-6 receptor antibodies in the second and third trimester of pregnancy: a retrospective cohort studyThe Lancet Rheumatology, 2024
- British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroidsRheumatology, 2022
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19New England Journal of Medicine, 2021
- Placental transfer of tocilizumab in a patient with rheumatoid arthritisRheumatology, 2019
- Tocilizumab: A Review in Rheumatoid ArthritisDrugs, 2017
- Amniotic Fluid EmbolismObstetrics & Gynecology, 2014